Steve Orndorff

Title: **Steve Orndorff: Innovator in Autoimmunity Treatments**

Introduction

Steve Orndorff is an accomplished inventor based in Broomfield, Colorado. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With three patents to his name, his innovations underline the importance of research in developing advanced therapeutic methods.

Latest Patents

Orndorff's latest patents focus on groundbreaking methods and compounds for treating autoimmunity. One notable patent details compounds and compositions useful in methods of treating or inhibiting the development of autoimmune diseases, including Celiac disease. This innovation works by modulating the binding of DQ8 MHC class II molecules to antigenic peptides. Another significant patent describes methods for administering methyldopa to increase its bioavailability when a subject is in a fasting state. These patents showcase his commitment to exploring new therapeutic avenues for managing complex health issues.

Career Highlights

Throughout his career, Orndorff has held positions at prominent institutions such as the University of Colorado and Immunomolecular Therapeutics, Inc. His work at these organizations has allowed him to collaborate with other talented professionals, driving forward research that has the potential to impact the treatment landscape for autoimmune conditions.

Collaborations

Steve Orndorff has collaborated with notable coworkers, including Aaron Michels and Peter Gottlieb. These partnerships highlight the collaborative nature of innovation in the biomedical field, as such cooperation often leads to enhanced ideas and advancements in research.

Conclusion

In summary, Steve Orndorff stands out as a noteworthy inventor with a focus on developing innovative treatments for autoimmune diseases. His work, evidenced by his patents, continues to pave the way for future discoveries, demonstrating the critical role of inventors in advancing medical science.